Masahito Takagi
Overview
Explore the profile of Masahito Takagi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
361
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tanaka K, Miwa K, Takagi M, Sasaki M, Yakushiji Y, Kudo K, et al.
J Am Heart Assoc
. 2022 Mar;
11(6):e024749.
PMID: 35253443
Background The aim of this study was to determine the associations of cerebral small vessel disease (SVD) burden with renal dysfunction and albuminuria in patients taking oral antithrombotic agents. Methods...
2.
Polymeris A, Macha K, Paciaroni M, Wilson D, Koga M, Cappellari M, et al.
Ann Neurol
. 2021 Nov;
91(1):78-88.
PMID: 34747514
Objective: To investigate the safety and effectiveness of direct oral anticoagulants (DOAC) versus vitamin K antagonists (VKA) after recent stroke in patients with atrial fibrillation (AF) aged ≥85 years. Methods:...
3.
[A case of lower urinary tract dysfunction due to acute hemorrhage in the lateral medulla oblongata]
Eto F, Takagi M, Tanaka K, Morita Y, Tanimoto K, Toyoda K, et al.
Rinsho Shinkeigaku
. 2021 May;
61(6):392-397.
PMID: 34011814
A 67-year-old woman was transported to our hospital with abnormal sensation in the left temporal region and unstable gait. She had a history of increased urinary frequency without medication. Head...
4.
Anzai T, Sato T, Fukumoto Y, Izumi C, Kizawa Y, Koga M, et al.
Circ J
. 2021 Mar;
85(5):695-757.
PMID: 33775980
No abstract available.
5.
Takagi M, Tanaka K, Miwa K, Sasaki M, Koga M, Hirano T, et al.
Eur Stroke J
. 2021 Feb;
5(4):423-431.
PMID: 33598561
Aims: The bleeding risk of current antithrombotic strategies in clinical settings, including recently developed agents, needs to be clarified. Methods And Design: In an investigator-initiated, prospective, multicentre, observational study, patients...
6.
Cappellari M, Seiffge D, Koga M, Paciaroni M, Forlivesi S, Turcato G, et al.
Eur Stroke J
. 2021 Feb;
5(4):384-393.
PMID: 33598557
Introduction: It is unknown whether the type of treatment (direct oral anticoagulant versus vitamin K antagonist) and the time of treatment introduction (early versus late) may affect the functional outcome...
7.
Tokunaga K, Koga M, Yoshimura S, Okada Y, Yamagami H, Todo K, et al.
Cerebrovasc Dis
. 2020 Nov;
49(6):619-624.
PMID: 33176314
Background: The present study aimed to clarify the association between left atrial (LA) size and ischemic events after ischemic stroke or transient ischemic attack (TIA) in patients with nonvalvular atrial...
8.
Ikenouchi H, Takagi M, Nishimura A, Yamaguchi E, Koge J, Saito K, et al.
BMC Neurol
. 2020 Jul;
20(1):285.
PMID: 32693780
Background: Patients with vascular Ehlers-Danlos syndrome (EDS) occasionally suffer from arterial dissection. Eagle syndrome, which is caused by an elongated styloid process and also causes arterial dissection, is difficult to...
9.
Sato T, Sato S, Yamagami H, Komatsu T, Mizoguchi T, Yoshimoto T, et al.
J Neurol Sci
. 2020 Apr;
413:116814.
PMID: 32259707
Objective: To determine the predictors of unfavorable outcomes in acute minor ischemic stroke patients with large vessel occlusion. Methods: The derivation cohort included ischemic stroke patients admitted to a comprehensive...
10.
Seiffge D, De Marchis G, Koga M, Paciaroni M, Wilson D, Cappellari M, et al.
Ann Neurol
. 2020 Feb;
PMID: 32052481
Objective: It is not known whether patients with atrial fibrillation (AF) with ischemic stroke despite oral anticoagulant therapy are at increased risk for further recurrent strokes or how ongoing secondary...